Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

There are three different COVID vaccines to choose from this season: two mRNA vaccines from Pfizer and Moderna, and a protein ...

British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of ...

The lawsuit focuses on scientific work that helped clear the path for creating mRNA vaccines to fight the COVID-19 pandemic.

The most important thing to know is that the COVID vaccine is safe and effective, says Dr. Watkins. With that said, side effects from the COVID vaccine are rare, says Dr. Cennimo, and they usually ...

Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...

The lawsuits allege Moderna infringed on the company’s patents for lipid mRNA vaccine technology. The lawsuits stated Christian Mandl and his team of scientists are credited for developing novel ...